AR054804A1 - Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas - Google Patents

Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas

Info

Publication number
AR054804A1
AR054804A1 ARP060102758A ARP060102758A AR054804A1 AR 054804 A1 AR054804 A1 AR 054804A1 AR P060102758 A ARP060102758 A AR P060102758A AR P060102758 A ARP060102758 A AR P060102758A AR 054804 A1 AR054804 A1 AR 054804A1
Authority
AR
Argentina
Prior art keywords
alkyl
carbon atoms
alkyloxy
saturated hydrocarbon
group
Prior art date
Application number
ARP060102758A
Other languages
English (en)
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35447198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054804(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR054804A1 publication Critical patent/AR054804A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
ARP060102758A 2005-06-28 2006-06-27 Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas AR054804A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05105755 2005-06-28

Publications (1)

Publication Number Publication Date
AR054804A1 true AR054804A1 (es) 2007-07-18

Family

ID=35447198

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102758A AR054804A1 (es) 2005-06-28 2006-06-27 Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas

Country Status (32)

Country Link
US (1) US20130030016A1 (uk)
EP (1) EP1898909B1 (uk)
JP (1) JP5193857B2 (uk)
KR (1) KR101329587B1 (uk)
CN (1) CN101252927B (uk)
AP (1) AP2547A (uk)
AR (1) AR054804A1 (uk)
AU (1) AU2006263882B2 (uk)
BR (1) BRPI0613999B8 (uk)
CA (1) CA2612614C (uk)
CY (1) CY1119402T1 (uk)
DK (1) DK1898909T3 (uk)
EA (1) EA014431B1 (uk)
ES (1) ES2610472T3 (uk)
HK (1) HK1120732A1 (uk)
HR (1) HRP20170044T1 (uk)
HU (1) HUE030264T2 (uk)
IL (1) IL188395A (uk)
JO (1) JO3322B1 (uk)
LT (1) LT1898909T (uk)
MX (1) MX2008000079A (uk)
MY (1) MY173664A (uk)
NO (1) NO341285B1 (uk)
NZ (1) NZ564340A (uk)
PL (1) PL1898909T3 (uk)
PT (1) PT1898909T (uk)
RS (1) RS55601B1 (uk)
SG (1) SG166798A1 (uk)
TW (1) TWI413520B (uk)
UA (1) UA88701C2 (uk)
WO (1) WO2007000434A1 (uk)
ZA (1) ZA200711148B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JP5397881B2 (ja) * 2008-09-04 2014-01-22 昇一 城武 グラム陽性細菌用抗菌剤及び抗菌活性増強剤
MX355050B (es) 2012-04-27 2018-04-02 Janssen Pharmaceutica Nv Derivados de quinolina antibacterianos.
CN104254528B (zh) 2012-04-27 2017-06-06 詹森药业有限公司 抗菌的喹啉衍生物
WO2019071325A1 (en) * 2017-10-13 2019-04-18 The University Of Queensland ZINC IONOPHORES AND USES THEREOF
CN110606825A (zh) * 2019-10-30 2019-12-24 成都海杰亚医药科技有限公司 一种制备吡啶-2-硫醇的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
JP4484703B2 (ja) * 2002-07-25 2010-06-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キノリン誘導体およびミコバクテリア抑制剤としてのそれらの使用
KR20130024969A (ko) * 2004-05-28 2013-03-08 얀센 파마슈티카 엔.브이. 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린 유도체의 용도
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
EE05697B1 (et) * 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained

Also Published As

Publication number Publication date
BRPI0613999B1 (pt) 2020-04-22
KR20080028459A (ko) 2008-03-31
US20130030016A1 (en) 2013-01-31
BRPI0613999A2 (pt) 2011-03-01
TW200800183A (en) 2008-01-01
JO3322B1 (ar) 2019-03-13
EA200800151A1 (ru) 2008-06-30
ES2610472T3 (es) 2017-04-27
MY173664A (en) 2020-02-14
DK1898909T3 (en) 2017-02-06
RS55601B1 (sr) 2017-06-30
NZ564340A (en) 2011-02-25
KR101329587B1 (ko) 2013-11-15
CY1119402T1 (el) 2018-03-07
JP5193857B2 (ja) 2013-05-08
BRPI0613999B8 (pt) 2021-05-25
AU2006263882B2 (en) 2012-12-13
EP1898909A1 (en) 2008-03-19
EA014431B1 (ru) 2010-12-30
IL188395A0 (en) 2008-08-07
HK1120732A1 (en) 2009-04-09
IL188395A (en) 2012-05-31
CA2612614C (en) 2017-07-25
UA88701C2 (uk) 2009-11-10
CA2612614A1 (en) 2007-01-04
TWI413520B (zh) 2013-11-01
HUE030264T2 (en) 2017-04-28
PL1898909T3 (pl) 2017-03-31
NO20080499L (no) 2008-02-29
AU2006263882A1 (en) 2007-01-04
NO341285B1 (no) 2017-10-02
SG166798A1 (en) 2010-12-29
EP1898909B1 (en) 2016-10-19
CN101252927A (zh) 2008-08-27
JP2008546824A (ja) 2008-12-25
LT1898909T (lt) 2017-02-10
ZA200711148B (en) 2013-03-27
WO2007000434A1 (en) 2007-01-04
PT1898909T (pt) 2016-12-07
HRP20170044T1 (hr) 2017-03-10
MX2008000079A (es) 2008-03-19
CN101252927B (zh) 2014-01-01
AP2547A (en) 2012-12-26

Similar Documents

Publication Publication Date Title
AR051790A1 (es) Tratamiento de tuberculosis latente
AR049127A1 (es) Uso de derivados quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a los farmacos
AR054804A1 (es) Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas
AR054889A1 (es) Derivados de quinolina como agentes bacterianos
AR040673A1 (es) Inhibidores micobacterianos, composicion farmaceutica y proceso de preparacion del compuesto
AR064151A1 (es) Derivados de quinolina antibacterianos, composiciones farmaceuticas que los contienen y metodo de preparacion.
RS53191B (en) HINOLINE DERIVATIVES AS ANTI-BACTERIAL AGENTS
DOP2018000187A (es) Derivados de pirazolo[1,5-a]pirazin-4-ilo
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
RU2487124C2 (ru) Новое амидное производное и его использование в качестве лекарственного средства
TR201906123T4 (tr) P13 kinazı ve mtor inhibitörleri olarak triazin bileşikleri.
RS20050522A (en) Protein kinase inhibiting tricyclic compounds that increase the effects of anti-neoplastic agents and therapeutic radiation
BRPI0509359A (pt) compostos de porfirina substituìda por piridila e métodos de empregos destes
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
SG149033A1 (en) Heterocyclic inhibitors of mek and methods of use thereof
MX2009003157A (es) Pirazoliltienopiridinas terapeuticas.
AR064153A1 (es) Derivados de quinolina antibacterianos. procesos de obtencion y composiciones farmaceuticas.
AR054587A1 (es) Derivados de quinolina antibacterianos
EA200901241A1 (ru) Соединения для лечения гепатита с
AR056321A1 (es) COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
EA200800508A1 (ru) Производные хинолина в качестве антибактериальных средств
AR054626A1 (es) Derivados de quinolina como agentes antibacterianos
FI3546462T3 (fi) Uusi oksoisokinoliinijohdannainen
RS52606B (en) QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
HRP20161704T1 (hr) Derivati kinolina kao antibakterijska sredstva

Legal Events

Date Code Title Description
FB Suspension of granting procedure